Barrett RP - Search Results

1

Jiang X, McClellan SA, Barrett RP, Zhang Y, Foldenauer ME, Hazlett LD. Jiang X, et al. Among authors: barrett rp. Invest Ophthalmol Vis Sci. 2012 Nov 7;53(12):7560-6. doi: 10.1167/iovs.12-10437. Invest Ophthalmol Vis Sci. 2012. PMID: 23074208 Free PMC article.

2

The role of nitric oxide in resistance to P. aeruginosa ocular infection.

Hazlett LD, McClellan S, Goshgarian C, Huang X, Thakur A, Barrett R. Hazlett LD, et al. Ocul Immunol Inflamm. 2005 Jul-Aug;13(4):279-88. doi: 10.1080/09273940590951016. Ocul Immunol Inflamm. 2005. PMID: 16159718

3

HGF signaling impacts severity of Pseudomonas aeruginosa keratitis.

Jiang X, McClellan SA, Barrett R, Foldenauer M, Hazlett LD. Jiang X, et al. Invest Ophthalmol Vis Sci. 2014 Apr 9;55(4):2180-90. doi: 10.1167/iovs.13-13743. Invest Ophthalmol Vis Sci. 2014. PMID: 24618323 Free PMC article.

4

Interleukin 17 regulates Mer tyrosine kinase-positive cells in Pseudomonas aeruginosa keratitis.

Li C, McClellan SA, Barrett R, Hazlett LD. Li C, et al. Invest Ophthalmol Vis Sci. 2014 Oct 8;55(10):6886-900. doi: 10.1167/iovs.14-14522. Invest Ophthalmol Vis Sci. 2014. PMID: 25298414 Free PMC article.

5

High-mobility group box 1: a novel target for treatment of Pseudomonas aeruginosa keratitis.

McClellan S, Jiang X, Barrett R, Hazlett LD. McClellan S, et al. J Immunol. 2015 Feb 15;194(4):1776-87. doi: 10.4049/jimmunol.1401684. Epub 2015 Jan 14. J Immunol. 2015. PMID: 25589066 Free PMC article.

6

The role of Langerhans cells in Pseudomonas aeruginosa infection.

Hazlett LD, McClellan SA, Rudner XL, Barrett RP. Hazlett LD, et al. Among authors: barrett rp. Invest Ophthalmol Vis Sci. 2002 Jan;43(1):189-97. Invest Ophthalmol Vis Sci. 2002. PMID: 11773031

7

Role of IL-12 and IFN-gamma in Pseudomonas aeruginosa corneal infection.

Hazlett LD, Rudner XL, McClellan SA, Barrett RP, Lighvani S. Hazlett LD, et al. Among authors: barrett rp. Invest Ophthalmol Vis Sci. 2002 Feb;43(2):419-24. Invest Ophthalmol Vis Sci. 2002. PMID: 11818386

8

IL-18 contributes to host resistance against infection with Pseudomonas aeruginosa through induction of IFN-gamma production.

Huang X, McClellan SA, Barrett RP, Hazlett LD. Huang X, et al. Among authors: barrett rp. J Immunol. 2002 Jun 1;168(11):5756-63. doi: 10.4049/jimmunol.168.11.5756. J Immunol. 2002. PMID: 12023376

9

Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro- and anti-inflammatory cytokines in BALB/c mice.

McClellan SA, Huang X, Barrett RP, van Rooijen N, Hazlett LD. McClellan SA, et al. Among authors: barrett rp. J Immunol. 2003 May 15;170(10):5219-27. doi: 10.4049/jimmunol.170.10.5219. J Immunol. 2003. PMID: 12734370

10

Caspase-1 inhibitor reduces severity of pseudomonas aeruginosa keratitis in mice.

Thakur A, Barrett RP, Hobden JA, Hazlett LD. Thakur A, et al. Among authors: barrett rp. Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3177-84. doi: 10.1167/iovs.04-0041. Invest Ophthalmol Vis Sci. 2004. PMID: 15326138

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters